APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lemborexant Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lemborexant Tablets Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchLemborexant Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Lemborexant Tablets Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Lemborexant Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lemborexant Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Lemborexant Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lemborexant Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lemborexant Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lemborexant Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lemborexant Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lemborexant Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lemborexant Tablets market include Eisai. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lemborexant Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lemborexant Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lemborexant Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lemborexant Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Lemborexant Tablets Segment by Company

Eisai

Lemborexant Tablets Segment by Type

5 mg

2.5mg

10 mg

Lemborexant Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Lemborexant Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lemborexant Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lemborexant Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lemborexant Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Lemborexant Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lemborexant Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lemborexant Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lemborexant Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lemborexant Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lemborexant Tablets industry.

Chapter 3: Detailed analysis of Lemborexant Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lemborexant Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lemborexant Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lemborexant Tablets Industry Trends Table 2. Lemborexant Tablets Industry Drivers Table 3. Lemborexant Tablets Industry Opportunities and Challenges Table 4. Lemborexant Tablets Industry Restraints Table 5. Global Lemborexant Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lemborexant Tablets Revenue Share by Company (2021-2026) Table 7. Global Lemborexant Tablets Sales Volume by Company (k units) & (2021-2026) Table 8. Global Lemborexant Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Lemborexant Tablets Average Price (USD/unit) of Company (2021-2026) Table 10. Global Lemborexant Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lemborexant Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Lemborexant Tablets Company, Product Type & Application Table 13. Global Lemborexant Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lemborexant Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5 mg Table 18. Significant Companies of 2.5mg Table 19. Significant Companies of 10 mg Table 20. Global Lemborexant Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Lemborexant Tablets Sales Volume by Type (2021-2026) & (k units) Table 22. Global Lemborexant Tablets Sales Volume by Type (2027-2032) & (k units) Table 23. Global Lemborexant Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Lemborexant Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Lemborexant Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lemborexant Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Lemborexant Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Lemborexant Tablets Sales Value Share by Type (2021-2026) Table 29. Global Lemborexant Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital and Clinic Table 31. Significant Companies of Retail Pharmacies Table 32. Significant Companies of Other Table 33. Global Lemborexant Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Lemborexant Tablets Sales Volume by Application (2021-2026) & (k units) Table 35. Global Lemborexant Tablets Sales Volume by Application (2027-2032) & (k units) Table 36. Global Lemborexant Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Lemborexant Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Lemborexant Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Lemborexant Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Lemborexant Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Lemborexant Tablets Sales Value Share by Application (2021-2026) Table 42. Global Lemborexant Tablets Sales Value Share by Application (2027-2032) Table 43. Global Lemborexant Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Lemborexant Tablets Sales by Region (2021-2026) & (k units) Table 45. Global Lemborexant Tablets Sales Market Share by Region (2021-2026) Table 46. Global Lemborexant Tablets Sales by Region (2027-2032) & (k units) Table 47. Global Lemborexant Tablets Sales Market Share by Region (2027-2032) Table 48. Global Lemborexant Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Lemborexant Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Lemborexant Tablets Sales Value Share by Region (2021-2026) Table 51. Global Lemborexant Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Lemborexant Tablets Sales Value Share by Region (2027-2032) Table 53. Global Lemborexant Tablets Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Lemborexant Tablets Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Lemborexant Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Lemborexant Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Lemborexant Tablets Sales by Country (2021-2026) & (k units) Table 58. Global Lemborexant Tablets Sales Market Share by Country (2021-2026) Table 59. Global Lemborexant Tablets Sales by Country (2027-2032) & (k units) Table 60. Global Lemborexant Tablets Sales Market Share by Country (2027-2032) Table 61. Global Lemborexant Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Lemborexant Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Lemborexant Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Lemborexant Tablets Sales Value Market Share by Country (2027-2032) Table 65. Eisai Company Information Table 66. Eisai Business Overview Table 67. Eisai Lemborexant Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Eisai Lemborexant Tablets Product Portfolio Table 69. Eisai Recent Development Table 70. Key Raw Materials Table 71. Raw Materials Key Suppliers Table 72. Lemborexant Tablets Distributors List Table 73. Lemborexant Tablets Customers List Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Lemborexant Tablets Product Image Figure 2. Global Lemborexant Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lemborexant Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lemborexant Tablets Sales (2021-2032) & (k units) Figure 5. Global Lemborexant Tablets Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Lemborexant Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5 mg Image Figure 10. 2.5mg Image Figure 11. 10 mg Image Figure 12. Global Lemborexant Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Lemborexant Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Lemborexant Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Lemborexant Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Lemborexant Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Lemborexant Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital and Clinic Image Figure 19. Retail Pharmacies Image Figure 20. Other Image Figure 21. Global Lemborexant Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Lemborexant Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Lemborexant Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Lemborexant Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Lemborexant Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Lemborexant Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Lemborexant Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Lemborexant Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Lemborexant Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Lemborexant Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Lemborexant Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Lemborexant Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Lemborexant Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Lemborexant Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Lemborexant Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Lemborexant Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Lemborexant Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Lemborexant Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Lemborexant Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Lemborexant Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Lemborexant Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Lemborexant Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Lemborexant Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 2.5mg
  • 10 mg
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lemborexant Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Lemborexant Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Lemborexant Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lemborexant Tablets Market Dynamics
  1. 2.1 Lemborexant Tablets Industry Trends
  2. 2.2 Lemborexant Tablets Industry Drivers
  3. 2.3 Lemborexant Tablets Industry Opportunities and Challenges
  4. 2.4 Lemborexant Tablets Industry Restraints
3 Lemborexant Tablets Market by Company
  1. 3.1 Global Lemborexant Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Lemborexant Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Lemborexant Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Lemborexant Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Lemborexant Tablets Company Ranking (2024-2026)
  6. 3.6 Global Lemborexant Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Lemborexant Tablets Company Product Type and Application
  8. 3.8 Global Lemborexant Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lemborexant Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lemborexant Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lemborexant Tablets Market by Type
  1. 4.1 Lemborexant Tablets Type Introduction
  2. 4.1.1 5 mg
  3. 4.1.2 2.5mg
  4. 4.1.3 10 mg
  5. 4.2 Global Lemborexant Tablets Sales Volume by Type
  6. 4.2.1 Global Lemborexant Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lemborexant Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Lemborexant Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Lemborexant Tablets Sales Value by Type
  10. 4.3.1 Global Lemborexant Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Lemborexant Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Lemborexant Tablets Sales Value Share by Type (2021-2032)
5 Lemborexant Tablets Market by Application
  1. 5.1 Lemborexant Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Lemborexant Tablets Sales Volume by Application
  6. 5.2.1 Global Lemborexant Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lemborexant Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lemborexant Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lemborexant Tablets Sales Value by Application
  10. 5.3.1 Global Lemborexant Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lemborexant Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lemborexant Tablets Sales Value Share by Application (2021-2032)
6 Lemborexant Tablets Regional Sales and Value Analysis
  1. 6.1 Global Lemborexant Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lemborexant Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Lemborexant Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Lemborexant Tablets Sales by Region (2027-2032)
  5. 6.3 Global Lemborexant Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lemborexant Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lemborexant Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lemborexant Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Lemborexant Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lemborexant Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Lemborexant Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lemborexant Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Lemborexant Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lemborexant Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lemborexant Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lemborexant Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Lemborexant Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lemborexant Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lemborexant Tablets Sales Value Share by Country, 2025 VS 2032
7 Lemborexant Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Lemborexant Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lemborexant Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lemborexant Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Lemborexant Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Lemborexant Tablets Sales by Country (2027-2032)
  6. 7.4 Global Lemborexant Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lemborexant Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lemborexant Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lemborexant Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lemborexant Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lemborexant Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Lemborexant Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Lemborexant Tablets Product Portfolio
  6. 8.1.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lemborexant Tablets Value Chain Analysis
  2. 9.1.1 Lemborexant Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lemborexant Tablets Sales Mode & Process
  6. 9.2 Lemborexant Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lemborexant Tablets Distributors
  9. 9.2.3 Lemborexant Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst